 | | DRUG: Heparin sodium | |
| Entry |
|
|---|
| Name |
Heparin sodium (JP18/USP/INN);
Parnaparin sodium (INN);
Liquemin sodium (TN) |
|---|
| Product |
HEPARIN SODIUM (Cardinal Health 107), HEPARIN SODIUM (Cardinal Health 107), HEPARIN SODIUM (Cardinal Health 107), HEPARIN SODIUM (Civica), HEPARIN SODIUM (Fresenius Kabi USA), HEPARIN SODIUM (Fresenius Kabi USA), HEPARIN SODIUM (Fresenius Kabi USA), HEPARIN SODIUM (Fresenius Kabi USA), HEPARIN SODIUM (Fresenius Kabi USA), HEPARIN SODIUM (Fresenius Kabi USA), HEPARIN SODIUM (Fresenius Kabi USA), HEPARIN SODIUM (HF Acquisition Co LLC), HEPARIN SODIUM (HF Acquisition Co LLC), HEPARIN SODIUM (Henry Schein), HEPARIN SODIUM (Hikma Pharmaceuticals USA), HEPARIN SODIUM (Hospira), HEPARIN SODIUM (Hospira), HEPARIN SODIUM (Pfizer Laboratories Div Pfizer), HEPARIN SODIUM (Phlow Corporation), HEPARIN SODIUM AND DEXTROSE (Hospira), HEPARIN SODIUM IN DEXTROSE (A-S Medication Solutions), HEPARIN SODIUM IN DEXTROSE (B. Braun Medical), HEPARIN SODIUM IN SODIUM CHLORIDE (B. Braun Medical), HEPARIN SODIUM IN SODIUM CHLORIDE (Baxter Healthcare Corporation), HEPARIN SODIUM IN SODIUM CHLORIDE (HF Acquisition Co LLC) |
|---|
| Generic |
HEPARIN SODIUM (B. Braun Medical), HEPARIN SODIUM (BE Pharmaceuticals), HEPARIN SODIUM (BE Pharmaceuticals), HEPARIN SODIUM (Cardinal Health 107), HEPARIN SODIUM (Cardinal Health 107), HEPARIN SODIUM (Cardinal Health 107), HEPARIN SODIUM (Cardinal Health 107), HEPARIN SODIUM (Fresenius Kabi USA), HEPARIN SODIUM (Fresenius Kabi USA), HEPARIN SODIUM (Gland Pharma Limited), HEPARIN SODIUM (HF Acquisition Co LLC), HEPARIN SODIUM (HF Acquisition Co LLC), HEPARIN SODIUM (HF Acquisition Co LLC), HEPARIN SODIUM (Henry Schein), HEPARIN SODIUM (Henry Schein), HEPARIN SODIUM (Hepalink USA), HEPARIN SODIUM (Hospira), HEPARIN SODIUM (Hospira), HEPARIN SODIUM (McKesson Corporation dba SKY Packaging), HEPARIN SODIUM (Meitheal Pharmaceuticals), HEPARIN SODIUM (Meitheal Pharmaceuticals), HEPARIN SODIUM (Meitheal Pharmaceuticals), HEPARIN SODIUM (Meitheal Pharmaceuticals), HEPARIN SODIUM (Meitheal Pharmaceuticals), HEPARIN SODIUM (Meitheal Pharmaceuticals), HEPARIN SODIUM (Mylan Institutional LLC), HEPARIN SODIUM (Mylan Institutional LLC), HEPARIN SODIUM (NorthStar RxLLC), HEPARIN SODIUM (NorthStar RxLLC), HEPARIN SODIUM (NorthStar RxLLC), HEPARIN SODIUM (Sagent Pharmaceticals), HEPARIN SODIUM (Sagent Pharmaceuticals), HEPARIN SODIUM (Sagent Pharmaceuticals), HEPARIN SODIUM (Sagent Pharmaceuticals), HEPARIN SODIUM (Sandoz) |
|---|
| Class |
Blood modifier agent
DG01950 Antithrombotic agent
DG01709 Heparin anticoagulant
|
|---|
| Remark |
| Therapeutic category: | 3334 |
| Product (DG00150): | D02112<JP/US> D04427<JP> D03674<JP/US> D04977<JP> D03353<JP/US> |
| Product (mixture): | D12737<US> |
|
|---|
| Efficacy |
Anticoagulant, Antithrombin III activator |
|---|
| Disease |
Disseminated intravascular coagulation [DS: H01587] |
|---|
| Target |
|
|---|
| Pathway |
| hsa04610 | Complement and coagulation cascades |
|
|---|
| Interaction |
|
|---|
| Structure map |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
B BLOOD AND BLOOD FORMING ORGANS
B01 ANTITHROMBOTIC AGENTS
B01A ANTITHROMBOTIC AGENTS
B01AB Heparin group
B01AB01 Heparin
D02112 Heparin sodium (JP18/USP/INN) <JP/US>
C CARDIOVASCULAR SYSTEM
C05 VASOPROTECTIVES
C05B ANTIVARICOSE THERAPY
C05BA Heparins or heparinoids for topical use
C05BA03 Heparin
D02112 Heparin sodium (JP18/USP/INN) <JP/US>
S SENSORY ORGANS
S01 OPHTHALMOLOGICALS
S01X OTHER OPHTHALMOLOGICALS
S01XA Other ophthalmologicals
S01XA14 Heparin
D02112 Heparin sodium (JP18/USP/INN) <JP/US>
USP drug classification [BR:br08302]
Blood Products and Modifiers
Anticoagulants
Heparin/ Heparinoids
Heparin Sodium
D02112 Heparin sodium (JP18/USP/INN)
Therapeutic category of drugs in Japan [BR:br08301]
3 Agents affecting metabolism
33 Blood and body fluid agents
333 Anticoagulants
3334 Heparins
D02112 Heparin sodium (JP18/USP/INN); Parnaparin sodium (INN)
Classification of Japanese OTC drugs [BR:br08313]
Agents for integumentary system
55 Chilblain and chap remedies
D02112 Heparin sodium (JP18/USP/INN)
Risk category of Japanese OTC drugs [BR:br08312]
Second-class OTC drugs
Inorganic and organic chemicals
Heparin sodium
D02112 Heparin sodium (JP18/USP/INN)
Drug groups [BR:br08330]
Blood modifier agent
DG01950 Antithrombotic agent
DG01709 Heparin anticoagulant
DG00150 Heparin
D02112 Heparin sodium
Target-based classification of drugs [BR:br08310]
Not elsewhere classified
Organismal systems
Complement and coagulation
SERPINC1 (AT3)
D02112 Heparin sodium (JP18/USP/INN) <JP/US>
Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
Chemicals
D02112 Heparin sodium
D02112 Heparin sodium injection
D02112 Heparin sodium solution for dialysis
D02112 Heparin sodium lock solution
Drug groups [BR:br08330]
Blood modifier agent
DG01950 Antithrombotic agent
DG01709 Heparin anticoagulant
DG00150 Heparin
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
|
» Japanese version » Back
|